Blog Post
Reimagining Pharmaceutical Manufacturing: Why the latest E2500-25 Standard Revision Demands Immediate Action
Speed to patient is a primary driver behind the industry's shift toward modern commissioning and qualification (C&Q) practices, while still ensuring product quality and patient...
Read More
Blog Post
Biotech’s QRM is All-Around Changes in the ICH Q9 Guideline
To foster greater success and reduce failure rates within the biotechnology industry, it has become imperative for companies to establish robust risk management plans. Quality...
Read More